CEM(SZ:002980) Shang Hai Zheng Quan Bao·2025-08-26 02:10Core Insights - The company reported a revenue of 349.39 million yuan for the first half of 2025, with a growth rate of 4.91% compared to the previous year [1] - The net profit remained stable year-on-year after deducting share-based payment expenses of 17.04 million yuan [1] - The company is focusing on optimizing its product structure, with core product segments including professional instruments, testing instruments, and medical diagnostic equipment showing a revenue growth of 13.85% [1] Revenue Breakdown - Revenue from professional instruments reached 157.56 million yuan, marking a year-on-year increase of 12.11% [1] - Sales of professional testing and scientific analysis instruments amounted to 40.72 million yuan, reflecting a growth of 16.42% [2] - Medical diagnostic and life science analysis instruments achieved sales of 4.36 million yuan, a significant increase of 76.68% [2] Strategic Developments - The company is enhancing its core competitiveness in intelligent measurement solutions, focusing on the development of AI-based measurement devices [1][3] - A dedicated artificial intelligence department has been established to keep pace with technological advancements and to develop next-generation intelligent detection equipment [3] - The company is expanding its overseas operations, particularly in Vietnam, to meet growing international demand and enhance its competitive edge [2]